Basic research discoveries not translating to clinical development, limited infrastructure for translational work, funding gaps, and no clear pathway from bench to bedside.
Translational research program development with infrastructure buildout, funding strategy, industry partnerships, regulatory pathway planning, and clinical trial design support.
- 5 novel drug candidates advanced to IND‑enabling studies
- $15M industry partnership funding secured
- 2 Phase I clinical trials initiated within 3 years
Proves translational research infrastructure can effectively bridge academic discovery and clinical development.
- GLP‑compliant tox testing facility established
- IND regulatory strategy and submission support
- Industry partnership agreements with 3 pharmaceutical companies
